SEM: Select Medical Holdings Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Is it worth investing in the Select Medical (SEM) ecosystem, which integrates rehabilitation and intensive care? The shift in the EV/EBITDA ratio clearly demonstrates the market valuation of the business inclusive of debt, where the 11.64 indicator determines the parameter status. Strict licensing barriers guarantee the company's stability, while strategic partnerships with hospital networks effectively block competitor expansion.
SEM (selectmedical.com): analytical breakdowns and indicator data
- stock price and consensus target price:
- market capitalization information:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Capital Select Medical|SEM - Long-Term Liabilities to Capital|Short-Term Debt to Capital Select Medical Holdings|SEM - Company Total Debt|Debt to Book Value Select Medical Inc.|SEM - Amount of Long-Term Liabilities|Company Current Liabilities Select Medical|Quick Liquidity selectmedical.com
- financial results and valuation multiples details:
SEM - Net Income|Projected Future Earnings Select Medical|SEM - Market Cap to Earnings|Forward P/E Multiple Select Medical|SEM - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Select Medical Inc.|SEM - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Select Medical|SEM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth selectmedical.com|SEM - Earnings growth in current year|Net earnings per share growth forecast for next year Select Medical
Analysis of all company metrics:Select Medical Corp (SEM)
This multiple compares the total enterprise value, including net debt, to its operating profit before depreciation and amortization, determining the asset payback period regardless of the tax regime. As Select Medical (SEM) prepares for the spin-off of a major asset, the EV/EBITDA valuation metric, which measures debt and operating leverage, allows for tracking the impact of structural changes and joint ventures on the company's investment attractiveness.
Competing companies
HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|FMS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio solventum.com SOLV|EHC: EV/EBITDA Multiple|Company Value to EBITDA Universal Health Services, Inc. (UHS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RDNT|EV/EBITDA Multiple OPCH|SGRY - Company Value to EBITDA|EV/EBITDA Multiple PINC (Premier)|EYE - Enterprise Value to EBITDA Ratio|PGNY: Enterprise Value to EBITDA Ratio|Ardent Health Corp - Enterprise Value to Operating Income Before Depreciation Ratio|ASTH (Astrana Health, Inc.) - Enterprise Value to EBITDA Ratio|Pediatrix Medical Group - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization US Physical Therapy|Enterprise Value to EBITDA Ratio Pennant Group (PNTG)|EV/EBITDA Multiple ORGO|NUTX - Company Value to EBITDA|EV/EBITDA Multiple AUNA (Auna SA)|SBC: Enterprise Value to Operating Income Before Depreciation|Evolus - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio CHS CYH|SKIN: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MediWound|BTMD (biote Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple thejoint.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DocGo (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PIII (p3hp.org)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gain Therapeutics, Inc. GANX|Total Company Value to Operating Income Before Depreciation Ratio euda.com (EUDA)|Basel Medical Group Limited - EV/EBITDA Multiple|Company Value to EBITDA CollPlant Biotechnologies|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Concord Medical Services Holdings|Enterprise Value to EBITDA Ratio AMS|MRM (MEDIROM Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalon GloboCare (ALBT)|DHAI (dih.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple XAGE (Carmell Therapeutics)|NewGenIvf Group (NIVF) - Company Value to EBITDA|ATI Physical Therapy Corp - EV/EBITDA Multiple|CMAX - EV/EBITDA Multiple|KDLY (Kindly MD, Inc.) - Enterprise Value to EBITDA Ratio|MODV: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Novo Integrated Sciences, Inc.|Enterprise Value to EBITDA Ratio SunLink Health Systems, Inc (SSY)|EV/EBITDA Multiple BACK
